Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Should TPIP’s New Clinical Data and Analyst Coverage Require Action From Insmed (INSM) Investors?

Insmed recently announced that it will present four abstracts on its treprostinil palmitil inhalation powder (TPIP) program for pulmonary arterial hypertension at the Pulmonary Vascular Research Institute 2026 congress, including Phase 2b topline results and Phase 3 trial design, and it also received new analyst coverage from Barclays. This combination of fresh clinical insight into TPIP and expanded analyst attention highlights how Insmed’s pulmonary pipeline is gaining increased medical...
TSE:7951
TSE:7951Leisure

Yamaha Finance Leaders Spotlighted As New Creator Tech Fund Opens Opportunities

Yamaha Music Innovations executives have been recognized on Billboard’s 2026 Finance 50 list. The company has launched a major venture capital fund focused on music and creative technologies. These developments highlight Yamaha’s role in supporting the broader creator ecosystem across music and related fields. For investors tracking TSE:7951, this combination of leadership recognition and a new fund illustrates how Yamaha is positioning itself within the music and creator technology space...
NasdaqGS:DRVN
NasdaqGS:DRVNConsumer Services

Do Persistent Negative Returns Mean Driven Brands (DRVN) Is Misusing Its Expansive Auto Service Footprint?

In recent commentary, analysts highlighted that Driven Brands Holdings' large North American auto service network has been held back by weak same-store sales over the past two years, raising questions about its pricing and marketing approach. An important concern is the company’s history of burning cash and recording negative returns on capital, which has prompted fresh scrutiny of whether its expansive footprint can translate into a sustainable business model. Against this backdrop, we’ll...
ASX:KAR
ASX:KAROil and Gas

Is Commonwealth Bank’s Exit Reframing Karoon Energy’s (ASX:KAR) Appeal To Long-Term Institutional Investors?

Commonwealth Bank of Australia and its related entities have notified Karoon Energy that they ceased to be a substantial holder in the company as of 26 January 2026, reducing their voting interest below the required disclosure threshold. This shift in institutional ownership could subtly reshape Karoon Energy’s shareholder base and influence how major investors engage with the offshore-focused producer. We’ll now explore how Commonwealth Bank of Australia’s reduced stake may influence Karoon...
NYSE:IP
NYSE:IPPackaging

International Paper Q4 Loss Of US$2.4b Challenges Bullish Recovery Narratives

International Paper (IP) just wrapped up FY 2025 with Q4 revenue of US$6.0b and a basic EPS loss of US$4.48, as discontinued operations and weaker earnings dragged the bottom line into the red. Over the past year, the company has seen quarterly revenue move from US$4,580m in Q4 2024 to US$6,006m in Q4 2025, while basic EPS shifted from a loss of US$0.42 to a loss of US$4.48, with trailing twelve month EPS at a loss of US$5.61. With the trailing twelve month net income also in loss territory,...
NasdaqGS:NVAX
NasdaqGS:NVAXBiotechs

Assessing Novavax’s (NVAX) Valuation After Its New Matrix M Licensing Agreement With Pfizer

Novavax (NVAX) is back in focus after the company signed a non exclusive License and Option Agreement with Pfizer, giving Pfizer access to its Matrix M adjuvant for vaccines targeting up to two infectious diseases. See our latest analysis for Novavax. The Pfizer agreement comes after a period of renewed interest in Novavax, with a 31.62% 1 month share price return and a 24.05% year to date share price return. However, the 5 year total shareholder return of a 96.95% loss shows that long term...